
135. Cholesterol Con with Malcolm Kendrick
The Bitcoin Standard Podcast
00:00
PCSK9 Inhibitors Are Not New, but They Are Being Used
PCSK9 inhibitors have been around for 150 years, but no one's ever heard of them. The only slight problem with them is they cost about 100 times as much as statin. If everybody in the UK swapped from taking a statin to a PCSK9 inhibitor, it would cost 90 billion pounds a year and that is the UK alone.
Transcript
Play full episode